Insulin analogues and their potential in the management of diabetes mellitus

被引：268

作者：

Bolli, GB

Di Marchi, RD

Park, GD

Pramming, S

Koivisto, VA

机构：

[1] Univ Perugia, DiMISEM, I-06126 Perugia, Italy

[2] Lilly Res Labs, Indianapolis, IN USA

[3] Hoechst Marion Roussel, Bridgewater, NJ USA

[4] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark

[5] Lilly Res Labs, Hamburg, Germany

来源：

DIABETOLOGIA | 1999年 / 42卷 / 10期

关键词：

D O I：

10.1007/s001250051286

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1151 / 1167

页数：17

共 156 条

[1] Optimal provision of daytime NPH insulin in patients using the insulin analog lispro [J].

Ahmed, ABE ;

Home, PD .

DIABETES CARE, 1998, 21 (10) :1707-1713

[2] Optimization of evening insulin dose in patients using the short-acting insulin analog lispro [J].

Ahmed, ABE ;

Mallias, J ;

Home, PD .

DIABETES CARE, 1998, 21 (07) :1162-1166

[3] The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients [J].

Ahmed, ABE ;

Home, PD .

DIABETES CARE, 1998, 21 (01) :32-37

[4] Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus [J].

Anderson, JH ;

Brunelle, RL ;

Keohane, P ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1249-1255

[5] Improved mealtime treatment of diabetes mellitus using an insulin analogue [J].

Anderson, JH ;

Brunelle, RL ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R ;

Cameron, DP ;

Yeu, DK ;

Zimmet, P ;

Lauvaux, JP ;

VanGaal, LF ;

Chiasson, JL ;

Fettes, IM ;

Tan, MH ;

Toth, EL ;

Charbonnel, B ;

Selam, JL ;

Haslbeck, M ;

SchulzeSchleppinghoff, B ;

Karasik, A ;

Hazenberg, HJ ;

VanDoorn, LG ;

Bonnici, FB ;

Hough, S ;

Mollentze, WF ;

Moore, R ;

Omar, MA ;

Robertson, LI ;

VanRooyen, RJ ;

DeLeiva, A ;

Jara, A ;

Vazquez, JA ;

Arslanian, S ;

Bastyr, EJ ;

Bergenstal, RM ;

Blonde, L ;

Boyce, PA ;

Chase, HP ;

Clarke, DH ;

Davidson, J ;

Garber, A ;

Goldberg, RB ;

Guthrie, RA ;

Mayfield, RK ;

Mengel, MC ;

Prince, MJ ;

Reeves, ML ;

Rosenzweig, JL ;

Schade, DS ;

Soeldner, JS .

CLINICAL THERAPEUTICS, 1997, 19 (01) :62-72

[6] Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment [J].

Anderson, JH ;

Brunelle, RL ;

Koivisto, VA ;

Pfutzner, A ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R ;

Bowen, KM ;

Cameron, DP ;

Nankervis, AJ ;

Roberts, AP ;

Zimmet, P ;

Borkenstein, MH ;

Schernthaner, G ;

Waldhausl, WK ;

DeLeeuw, IH ;

Fery, F ;

Scheen, A ;

Somers, G ;

Fettes, IM ;

Tildesley, HD ;

Toth, EL ;

Viikari, J ;

Altman, JJ ;

Bougneres, PF ;

Drouin, P ;

Fossati, P ;

Guillausseau, PJ ;

Marechaud, E ;

Riou, JP ;

Selam, JL ;

Vialettes, PB ;

Beyer, J ;

Federlin, K ;

Fussganger, RD ;

Gries, FA ;

Jastram, HU ;

Koop, I ;

Landgraf, R ;

Rosak, C ;

Schatz, H ;

SchulzeSchleppinghoff, B ;

Seif, FJ ;

Stoeckmann, F ;

Karasik, A ;

Weitzman, S ;

Andreani, D ;

Bompiani, G ;

Crepaldi, G ;

Giorgino, R .

DIABETES, 1997, 46 (02) :265-270

[7]

Anderson JH, 1998, DRUG TODAY, V34, P37

[8]

[Anonymous], 1996, DIABETES, V45, P1289

[9] Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM [J].

Attia, N ;

Jones, TW ;

Holcombe, J ;

Tamborlane, WV .

DIABETES CARE, 1998, 21 (05) :817-821

[10] Growth promoting and metabolic activity of the human insulin analogue [Gly(A21),Arg(B31),Arg(B32)]insulin (HOE 901) in muscle cells [J].

Bahr, M ;

Kolter, T ;

Seipke, G ;

Eckel, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (2-3) :259-265

← 1 2 3 4 5 6 7 8 9 10 →